Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
SAN DIEGO, CA / / May 15, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq;DRMAW) ('Dermata,' or the 'Company'), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions,